前收市價 | 2.30 |
開市 | 6.46 |
買盤 | 5.70 |
賣出價 | 6.00 |
拍板 | 240.00 |
到期日 | 2024-07-19 |
今日波幅 | 5.84 - 7.00 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 200 |
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
BD's (BDX) robust product portfolio raises optimism about the stock.
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.